Taylor Alyssa Kalomeris

Dr. Taylor Alyssa Kalomeris


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2024 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
CMCynthia M. Magro
Cynthia M. Magro
NCNeil Crowson
Neil Crowson
TKTaylor Alyssa Kalomeris
Taylor Alyssa Kalomeris
GNGerard Nuovo
Gerard Nuovo

2 January 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
CSCarla Stephan
Carla Stephan
TKTaylor Alyssa Kalomeris
Taylor Alyssa Kalomeris
Yaxin LiYaxin Li
Yaxin Li
JKJeffrey Kubiak
Jeffrey Kubiak
SRSabrina Racine-Brzostek
Sabrina Racine-Brzostek
HYHe Sarina Yang
He Sarina Yang
Background: Creutzfeldt–Jakob disease (CJD) is a rare, fatal, and transmissible neurodegenerative disorder caused by prion proteins. Handling specimens from individuals with suspected or confirmed cases presents a safety challenge to hospital workers including clinical laboratory staff. As no national guidelines exist, the clinical pathology laboratory must establish protocols for handling these specimens to ensure sufficient protective measures. This study aims to explore how various medical institutions manage CJD specimens, as a first step toward developing standardized preanalytical protocols for safe specimen handling by health care professionals. Methods: An electronic survey was generated and disseminated to diplomats of the American Board of Clinical Chemistry and was posted on the Listserv platform of the American Society for Microbiology and the Artery forum of the Association for Diagnostics and Laboratory Medicine. The survey evaluated various procedures and precautions implemented, the nature of the specimens processed, and whether they are processed in-house or sent to reference laboratories. Results: A total of 49 responses were collected. Most respondents (64%) noted their laboratories process specimens with a clinical suspicion of CJD regardless of the level of suspicion, 13% handled specimens only if the degree of suspicion was low, and 16% did not process specimens in-house at all. Among those who process CJD specimens, practices varied greatly, including different levels of precautions, use of biological safety cabinets, aliquoting, disposal, and disinfection procedures. Conclusions: A lack of standardization across laboratories exists for the handling of specimens of patients with suspected CJD. This study summarizes the approaches reported by survey respondents, providing a rationale for developing protocols for the safe handling of these specimens and highlighting the need to develop uniform universal standardized processing procedures.

16 December 2023 in Journal of Cutaneous Pathology
Verified
Journal Article
Closed access
TKTaylor Alyssa Kalomeris
Taylor Alyssa Kalomeris
MGMarc E. Grossman
Marc E. Grossman
JTJeffrey Tepler
Jeffrey Tepler
CMCynthia M. Magro
Cynthia M. Magro

7 September 2026 in Virchows Archiv
Verified
Journal Article
Closed access
PDF file
TKTaylor Alyssa Kalomeris
Taylor Alyssa Kalomeris
JCJeffrey M Cloutier
Jeffrey M Cloutier
SRShira Ronen
Shira Ronen
CLCecilia Lezcano
Cecilia Lezcano
MPMelissa P Pulitzer
Melissa P Pulitzer
KLKonstantinos Linos
Konstantinos Linos